Potentia Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Potentia Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT00473928) | Potentia Pharmaceuticals, Inc. | 2007-05-01 |
Track Potentia Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.